Welltower Inc
NYSE: WELL · REAL ESTATE · REIT - HEALTHCARE FACILITIES
Updated 2026-04-29
Welltower Inc (WELL) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
Welltower reported Q4 2025 revenue of $3.18B with 41.33% YoY growth and raised full-year 2026 EPS guidance. Management has demonstrated strong execution on acquisition pipeline and portfolio optimization, with normalized FFO growth and a 10% dividend increase signaling confidence in sustained mid-to-high single-digit revenue growth trajectory through 2026-2027.
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.5B | $7.9B | $10.7B | $13.9B | $14.8B | $15.7B | $17.6B | $19.2B |
| Revenue growth | — | 21.2% | 35.8% | 28.7% | 6.1% | 6.0% | 8.9% | 8.8% |
| EPS | $0.64 | $1.71 | $1.81 | $2.99 | $3.14 | $3.35 | $3.85 | $4.20 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $242.80 | $263.03 | $283.26 | $303.50 | $343.96 |
Catalysts & risks
Methodology
Welltower Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 12 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.